§ 601.40. Scope.
52 words·~1 min read·
/us/cfr/t21/s§ 601.40·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
This subpart applies to certain biological products that have been studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit to patients over existing treatments (e.g., ability to treat patients unresponsive to, or intolerant of, available therapy, or improved patient response over available therapy).
Connections2 cite this
Cited by 2 sections
Citation graph
cites case law
§ 601.40
Scope.
Fed. Reg.×2
Cites 0Cited by 2 across 1 source